UT-Battelle Licenses Tissue Regeneration Technologies to NellOne Therapeutics, Inc.
Thursday, January 28, 2010 - 16:49
in Mathematics & Economics
In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of the Department of Energy laboratory.